Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
GENNEX LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.75153.7027.91-4.2368.10

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 23.75 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.75
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 23.75
-84.55
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹230.6 Cr -4.6% -20.5% -27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-4.6%

-20.5%

-27.2%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses